In recent decades, quantitative transcription assays using bacterial RNA polymerase (RNAP) have been performed under widely diverse experimental conditions. We demonstrate that the template choice can influence the inhibitory potency of RNAP inhibitors. Furthermore, we illustrate that the sigma factor ( 70 ) surprisingly increases the transcription efficiency of templates with nonphysiological nonprokaryotic promoters. Our results might be a useful guideline in the early stages of using RNAP for drug discovery.
A
s bacterial RNA polymerase (RNAP) is essential for bacterial growth and survival, it is an attractive target for drug development (11, 29) . Several RNAP inhibitors have been described, ranging from highly active natural products (21) (22) (23) 39) to small organic molecules (3, 5, 6) . For the discovery of new drugs targeting this enzyme, reliable and comparable in vitro test systems are fundamental.
In the literature, a wide range of methods for investigating the inhibitory potential of RNAP inhibitors in vitro has been described, for example, with different sources of RNAPs (4, 5, 6, 8, 21, 25, 30, 36) or detection methods (4-6, 8, 15, 18, 21, 23-25, 36, 41, 42) . Additionally, many different DNA templates have been utilized, ranging from genomic DNA from eukaryotes (21) (22) (23) 25) or bacteriophages (8, 25, 27, 37) to plasmids (3-5, 18, 36) , PCR products (9, 35) , and promoter-lacking artificial templates such as poly(dA · dT) (18, 24, 42) and small circular single-stranded DNA (ssDNA) molecules (30, 33, 41) .
Surprisingly, the effect of the template choice on transcription and inhibitory activities of compounds has not been examined so far. For better comparability and easier evaluation of published RNAP inhibition values, we examined these effects by investigating the influence of 10 different DNA templates (Table 1 ) on inhibitory activities of nine characterized RNAP inhibitors. Furthermore, we focused on the role of 70 during transcription of templates lacking prokaryotic promoters.
Detailed information concerning the materials and methods used can be found in the supplemental material.
During transcription, the DNA templates act as indispensable catalysts which should be provided in concentrations that do not limit this enzymatic reaction. Consequently, the template concentrations were optimized for transcription reactions (see Fig. S1 in the supplemental material). Ideal DNA concentrations (the lowest at which saturation is reached) for the reactions were specified ( Table 2 ) and used during the subsequent experiments.
The role of 70 within the bacterial RNAP is to recognize defined promoter elements and to stabilize the melted DNA in the transcription bubble (10, 19, 28, 34) , even though it has been reported that the core enzyme alone (without ) can initiate transcription in the absence of promoters by starting at duplex ends or single-stranded regions (2, 14, 16, 32) . Surprisingly, employing RNAP core enzyme (␣ 2 ␤␤=) along with the promoter-lacking ssDNA template Kool NC-45 yielded more than four times less transcripts than using the holo-RNAP (␣ 2 ␤␤=) (Fig. 1A , left).
To confirm this finding, we performed transcription reactions with core enzyme in either the presence or absence of a self-purified Escherichia coli 70 factor. Again, the transcription rates were increased in the presence of 70 (Fig. 1A , right). Intrigued by these results, we decided to examine whether this effect also occurs when poly(dA · dT) or calf thymus DNA is employed both lacking physiological prokaryotic promoters, and we observed effects similar to those observed for Kool NC-45 ( Fig. 1B and C) . The fact that significantly more transcripts are formed when the RNAP holoenzyme is used could also be visualized by formaldehyde agarose gel electrophoresis (see Fig. S2 in the supplemental material).
These findings are not consistent with the assumption that a DNA template without a promoter should be transcribed without any advantageous role of 70 . The positive influence of 70 on the transcription of calf thymus DNA could be explained by the high similarity between the eukaryotic TATA box (26) and the prokaryotic Ϫ10 region. Because of our results with Kool NC-45 mimicking a transcription bubble and the easy-to-melt template poly(dA · dT) (1, 20) , we emphasize the importance of the transcription bubble-stabilizing role of 70 during transcription initiation, which seems to be the reason for the observed positive influence of 70 in these experiments. Next we analyzed whether the DNA template choice influences the inhibitory potency of nine RNAP inhibitors. The 50% inhibitory concentrations (IC 50 s) were determined for all of them. As shown in Fig. 2 (also, see Fig. S3 in the supplemental material), the use of dsDNA templates containing classical promoters (templates 1 to 8 [ Table 1 ]) had only a negligible effects on the potency of the inhibitors.
Strikingly, the use of poly(dA · dT) and the Kool templateboth lacking a physiological promoter-led to completely different results for some compounds. For CBR703, the IC 50 s were significantly decreased (Kool) or increased [poly(dA · dT)]. Even more strikingly, the IC 50 s of myxopyronin (only for Kool) and lipiarmycin were significantly increased (Fig. 2) .
The ␣-pyrone antibiotic myxopyronin was shown to target the RNAP switch region (7, 33, 40) , which is the hinge that mediates opening and closing of the RNAP active-center cleft (12, 13, 17) . After myxopyronin captures the enzyme in the closed conformation, dsDNA cannot enter at the first step of transcription initiation. However, in this conformation there seems to be enough space to allow the entrance of ssDNA (33) , which has a smaller diameter (ϳ7 Å) than dsDNA (ϳ20 Å), resulting in lower values for inhibition by myxopyronin in the presence of Kool NC-45 ( Fig. 2; also, see Fig. S4 in the supplemental material) than those obtained with dsDNA templates. Interestingly, the inhibition by corallopyronin-which is very similar to myxopyronin and binds to the same pocket (31)-was not affected by Kool. This could be due to the fact that corallopyronin leads to a tighter closing of the RNAP active-center cleft, preventing entry of ssDNA.
The activity of lipiarmycin was shown to be dramatically decreased with Kool and poly(dA · dT) compared to the activity seen with templates 1 to 8. It was shown and confirmed by us (see Table S1 in the supplemental material) that this compound inhibits RNAP holoenzyme much more strongly than the core enzyme (38) . This could be due to the fact that lipiar- . (A) RNAP holoenzyme or core enzyme was used to transcribe 100 ng of single-stranded Kool NC-45 template (left). RNAP core enzyme was used to transcribe 28 ng (ideal concentration according to the manufacturer) of Kool NC-45 template in the presence and absence of the same molar amount (compared to core enzyme) of E. coli 70 factor (right). RNAP core enzyme was also used to transcribe 350 ng of poly(dA · dT) template (B) or 1,000 ng calf thymus DNA (C), each in the presence or absence of the same molar amount (compared to core enzyme) of E. coli 70 factor. The rate of transcription is shown in counts per minute (cpm), indicating the amount of RNA formed. Standard deviations are indicated by error bars. mycin impedes the process whereby the template DNA strand fits into the RNAP active-site cleft, which is essential for promoter melting and de novo initiation of RNA synthesis-a step which is mediated by parts of RNAP core and 70 region 3.2 (40) . If such a process is impaired, the use of a template in which a binding site is already given-by an artificial transcription bubble (Kool template) or an easy-to-melt sequence [poly(dA · dT)]-causes lipiarmycin to no longer be able to fully elicit its most important action.
Our study aims to contribute to the understanding and comparability of published RNAP inhibition values. We conclude that nonphysiological templates are not suitable for the determination of inhibitory potencies of compounds targeting bacterial RNAP and recommend that other groups use a double-stranded, preferentially prokaryotic promoter-containing DNA template for testing. In summary, our results provide valuable insights into the transcription initiation process and provide guidelines for the establishment of transcription assays which might be useful in the discovery of novel inhibitors targeting RNAP. 
